Figure 1 Host range of hepatitis E virus

Slides:

Advertisements

Similar presentations

Hepatitis A Last updated August Hepatitis A virus Associated with poor hygiene and sanitation - primarily transmitted from person-to-person via.

Advertisements

Figure 2 Genetic organization and translation of hepatitis E virus

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Imaging of a depressed intramucosal carcinoma

Figure 4 Activation of clopidogrel via cytochrome P450

Figure 5 Therapeutic paradigms for interfering with the brain–gut axis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Patients cured of HCV infection

Figure 2 A stage-based approach to the treatment of NAFLD

Figure 7 Management algorithm for patients with ACLF

Figure 1 Gut microorganisms at the intersection of several diseases

Figure 5 Lipid droplet consumption

Figure 3 Life cycle of hepatitis E virus

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Global epidemiology of common Clostridium difficile ribotypes

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Biosimilar development process

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 4 Giant lipid droplet formation

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Combination therapy for HCC

Figure 2 Modelling the effect of HCV treatment on reinfection in people who inject drugs Figure 2 | Modelling the effect of HCV treatment on reinfection.

Figure 4 Proinflammatory immune cells and their crosstalk in patients with IBD Figure 4 | Proinflammatory immune cells and their crosstalk in patients.

Figure 1 Definition and concept of ACLF

Figure 2 Switching of biologic agents and biosimilars

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

to the liver and promote patient-derived xenograft tumour growth

Figure 7 Example colonic high-resolution manometry

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 Pseudorelaxation as a consequence of

Figure 1 Environmental factors contributing to IBD pathogenesis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 13C-octanoic acid gastric emptying breath test

Figure 1 Median coverage and distribution by

Volume 154, Issue 4, Pages (March 2018)

in the UK (1961–2012), France (1961–2014) and Italy (1961–2010)

Figure 4 Towards more physiologically relevant 2D

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Possible therapeutic targets to decrease hepatic steatosis

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 5 High-resolution manometry studies performed

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 3 Strategies to improve liver regeneration

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 6 Assessment of colonic transit time with radiopaque markers

Figure 5 Systems biological model of IBS

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Volume 150, Issue 2, Pages e3 (February 2016)

Figure 4 Local species pools that contribute to the

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Distribution of markers of active HBV infection

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Schematic representation of hepatitis E virus (HEV) genotype 3 in developed countries. Schematic representation of hepatitis E virus (HEV) genotype 3 in.

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 2 Lifelong influences on the gut microbiome from

Figure 2 Classifications and appearance of CCAs

FOOD ILLNESS & PROBLEMS

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro

Figure 1 The spread of colorectal cancer metastases

Environmental reservoirs, routes of transmission, and clinical manifestations associated with Campylobacter species. Environmental reservoirs, routes of.

Presentation transcript:

Figure 1 Host range of hepatitis E virus Figure 1 | Host range of hepatitis E virus. The Orthohepevirus A genus is classified into hepatitis E virus (HEV) genotypes 1–8. Genotypes 1 and 2 are limited to human hosts and are transmitted via the faecal–oral route, primarily through contaminated water. Genotypes 3 and 4 have multiple hosts and can be transmitted to humans through the consumption of undercooked meats, including pork. Genotypes 5 and 6 are known to infect wild boar; however, it is unknown whether these genotypes can be transmitted to humans (although there have been reports of wild boar genotype 3 HEV transmission to humans). Finally, genotypes 7 and 8 infect dromedary and Bactrian camels, respectively. There has been one case reported of genotype 7 HEV transmission to a liver transplant patient who consumed camel meat and milk274. Nimgaonkar, I. et al. (2017) Hepatitis E virus: advances and challenges Nat. Rev. Gastroenterol. Hepatol. doi:10.1038/nrgastro.2017.150